We saw a strong performance by major biotech players, but a challenging environment for the rest of the industry. Read more in our 2013 industry report
Beyond Borders: global biotech report 2013
mHealth: Mobile tech poised to enable new era in health care
The shifting pharmaceutical industry landscape
Pharma's $100 billion growth gap
Implementing the medical device excise tax
Pulse: medical technology report 2012
Cash on the prescription 2012
Beyond borders: global biotech report 2012
Progressions 2012: health care everywhere
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas:
| Lara Iob |
514 879 6514
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
11-12 March 2013
Philadelphia, Pennsylvania (US)
Join us at this premier event which brings together senior executives from leading product (pharma, medtech, biotech) companies along with payers, providers and policymakers to discuss the key issues that will set the product reimbursement agenda over the next few years.